ArticleEmerging infectious diseases2017
Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy.
Article in Emerging infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 21 citations in OpenAlex.
- Characterization of Unusual Serogroups ofMicroorganisms · 2024Article
- Genomic characterization of invasive meningococcal X isolates from Brazil, 1992-2022.International microbiology : the official journal of the Spanish Society for Microbiology · 2023Article
- Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil.Emerging infectious diseases · 2022Article
- Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy.Human vaccines & immunotherapeutics · 2021Article
- Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context.Human vaccines & immunotherapeutics · 2021Review
- Meningococcal infections among refugees and immigrants: silent threats of past, present and future.Human vaccines & immunotherapeutics · 2020Article
- Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine.NPJ vaccines · 2020Article
- Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events.Infectious diseases and therapy · 2019Review
- Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review.Infectious diseases and therapy · 2019Review
- Reply to "A refugee patient with meningococcal meningitis type B."Human vaccines & immunotherapeutics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 7 institutions in 2 countries.
Funding
Abstract
Four cases of infection with serogroup X meningococci (MenX) (1 in 2015 and 3 in 2016) occurred in migrants living in refugee camps or reception centers in Italy. All MenX isolates were identified as clonal complex 181. Our report suggests that serogroup X represents an emerging health threat for persons arriving from African countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.